Arvee Laboratories (India) Ltd. (NSE:ARVEE)

Market Cap	1.80B
Revenue (ttm)	353.65M
Net Income (ttm)	13.74M
Shares Out	11.02M
EPS (ttm)	1.24
PE Ratio	131.66
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	41
Average Volume	1,400
Open	164.00
Previous Close	163.61
Day's Range	159.00 - 164.00
52-Week Range	126.54 - 232.99
Beta	0.58
RSI	51.49
Earnings Date	Nov 13, 2025

About NSE:ARVEE

Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India. The company offers polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate; and contrast media intermediates, such as 5-nitroisophthalic acid, dimethyl 5-nitroisophthalate, monomethyl 5-nitroisophthalate, 5-hydroxyisophthalic acid, 5-aminoisophthalic acid, and dimethyl 5-aminoisophthalate, as well as 3,5-dinit...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 2012
• Employees: 70
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ARVEE

Financial Performance

In 2024, NSE:ARVEE's revenue was 384.87 million, an increase of 26.83% compared to the previous year's 303.45 million. Earnings were 21.47 million, an increase of 104.15%.